钟文昭

客座副教授

教育背景

博士(中山大学)

研究领域
肺癌多学科综合治疗和基础临床转化性研究
电子邮件
13609777314@163.com
个人简介

钟文昭教授2007年毕业于中山大学(胸部肿瘤外科学博士),主任医师。现任广东省肺癌研究所副所长,华南理工大学医学院、南方医科大学博士生导师。学术任职包含中国临床肿瘤学会理事,青年专家委员会委副主委,肺癌专业组长,国家自然科学基金评委,中华医学会肿瘤早诊早诊学组副组长,国际肺癌联盟IASLC官方杂志(J Thorac Oncol,IF 12.46)JTO 副主编,广东省医学会肺部肿瘤学分会副主任委员。
钟教授主要研究方向以肺癌外科为主单病种多学科综合治疗,包括IIIA期N2肺癌、肺部孤立结节/肺腺癌/GGO分类诊断和处理、胸腔镜微创肺癌根治术、肺癌病理分类和临床实践、人工智能影像-液体活检肺癌早筛分诊系统等;主持4项国家自然科学基金,研究结果发表在Lancet oncol(IF=35.386),J Clin Oncol(IF=28.245)*2,J Thorac Oncol(IF=12.46)*6,J Extracell Vesicles(IF=11)等杂志40余篇;他获得的奖励有国家科学技术进步奖二等奖(2018)、中华医学科技奖一等奖(2016)、广东省科学技术奖励一等奖(2010,2013)、广东省科学技术奖励二等奖(2016)。

学术著作

1. Wen-Zhao Zhong#, Qun Wang, Wei-Min Mao, Song-Tao Xu, Lin Wu, Yi Shen, Yong-Yu Liu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Ke Fei, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Hong-Hong Yan, Xue-Ning Yang, Qing Zhou, Yi-Long Wu*, on behalf of the ADJUVANT investigators; Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study, The Lancet Oncology, 2018, 19(1):139-148. (IF=35.386)
2. Wen-Zhao Zhong#, Si-Yang Liu, Yi-Long Wu*; Numbers or Stations: From Systematic Sampling to Individualized Lymph Node Dissection in Non–Small-Cell Lung Cancer, Journal of Clinical Oncology, 2017, 35(11):1143-1145. (IF=28.245)
3. Wen-Zhao Zhong#, Ke-Neng Chen, Chun Chen, Chun-Dong Gu, Jun Wang, Xue-Ning Yang, Wei-Min Mao, Qun Wang, Gui-Bin Qiao, Ying Cheng, Lin Xu, Chang-Li Wang, Ming-Wei Chen, Xiao-zheng Kang, Wan-pu Yan, Hong-Hong Yan, MARi-Qiang Liao, Jin-Ji Yang, Xu-Chao Zhang, Qing Zhou, Yi-Long Wu*; Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study, Journal of Clinical Oncology, 2019, 37(25):2235-2245. (IF=28.245)
4. Chao Zhang#, Li-Xu Yan, Ben-Yuan Jiang, Yi-Long Wu, Wen-Zhao Zhong*; Feasibility and Safety of Neoadjuvant Alectinib in a Patient With ALK-Positive Locally Advanced NSCLC, Journal of Thoracic Oncology, 2020, 15(6):e95-e99.. (IF=12.46)
5. Huan Lin#, Wen-Zhao Zhong#, Xue-Ning Yang, Xu-Chao Zhang, Jin-Ji Yang, Qing Zhou, Hong-Hong Yan, Ri-Qiang Liao, Qiang Nie, Song Dong, Yi-Long Wu*; A Clinical Model to Estimate the Pretest Probability of Lung Cancer, Based on 1198 Pedigrees in China, Journal of Thoracic Oncology, 2012, 7(10):1534-40. (IF=12.46)
6. Chao Zhang#, Shao-lei Li#, Qiang Nie, Song Dong, Yang Shao, Xue-ning Yang, Yi-long Wu, Yue Yang, Wen-zhao Zhong*; Neoadjuvant Crizotinib in Resectable Locally Advanced Non–Small Cell Lung Cancer with ALK Rearrangement, Journal of Thoracic Oncology, 2019, 14(4):726-731. (IF=12.46)
7. Song-Tao Xu#, Jun-Jie Xi#, Wen-Zhao Zhong#, Wei-Min Mao, Lin Wu, Yi Shen, Yong-Yu Liu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Ke Fei, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen,  Shi-Dong Xu, Lun-Xu Liu, Ping Yu,  Bu-Hai Wang, Hai-Tao M  Hong-Hong Yan, BS, Xue-Ning Yang, Yong-Xing Zhang, Jia-Cheng Yin, BS, Qun Wang, Yi-Long Wu*; The unique spatial–temporal treatment failure patterns of adjuvant gefitinib therapy: A post-hoc analysis of the ADJUVANT trial (CTONG 1104), Journal of Thoracic Oncology, 2019, 14(3):503-512. (IF=12.46)
8. Chao Zhang#, Jianjun Zhang#, Fang-Ping Xu, Yin-Guang Wang, Zhi Xie, Jian Su, Song Dong, Qiang Nie, Yang Shao, Qing Zhou, Jin-Ji Yang, Xue-Ning Yang, Xu-Chao Zhang, Zhi Li, Yi-Long Wu, Wen-Zhao Zhong*; Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early-Invasive Lung Adenocarcinoma, Journal of Thoracic Oncology, 2019, 14(11):1912-1923. (IF=12.46)
9. Chao Zhang#, Yi-Long Wu, Wen-Zhao Zhong*; Rapid Postoperative Relapse in ALK-Positive Locally Advanced NSCLC Patient with Complete Pathological Response to Neoadjuvant Crizotinib, Journal of Thoracic Oncology, 2019, 14(10):e234-e236. (IF=12.46)
10. Jia-Tao Zhang#, Hao Qin, Fiona Ka Man Cheung, Jian Su, Da-Dong Zhang, Shi-Yi Liu, Xiao-Fang Li, Jing Qin, Jun-Tao Lin, Ben-Yuan Jiang, Song Dong, Ri-Qiang Liao, Nie Qiang, Xue-Ning Yang, Hai-Yan Tu, Qing Zhou, Jin-Ji Yang, Xu-Chao Zhang, Ya-Nan Zhang, Yi-Long Wu*, Wen-Zhao Zhong*; Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules, Journal of Extracellular Vesicles, 2019, 8(1):1663666. (IF=11)